A detailed history of Formula Growth LTD transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Formula Growth LTD holds 128,125 shares of TNDM stock, worth $4.6 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares
128,125
Previous 124,646 2.79%
Holding current value
$4.6 Million
Previous $5.02 Million 8.19%
% of portfolio
1.99%
Previous 1.93%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$35.21 - $47.3 $122,495 - $164,556
3,479 Added 2.79%
128,125 $5.43 Million
Q2 2024

Aug 13, 2024

BUY
$30.43 - $53.43 $27,387 - $48,087
900 Added 0.73%
124,646 $5.02 Million
Q1 2024

May 14, 2024

BUY
$22.09 - $35.41 $1.83 Million - $2.94 Million
83,000 Added 203.7%
123,746 $4.38 Million
Q3 2023

Nov 13, 2023

BUY
$19.33 - $36.22 $328,610 - $615,740
17,000 Added 71.59%
40,746 $846,000
Q1 2023

May 12, 2023

SELL
$35.86 - $46.5 $842,961 - $1.09 Million
-23,507 Reduced 49.75%
23,746 $964,000
Q4 2022

Feb 13, 2023

BUY
$35.49 - $56.15 $124,215 - $196,525
3,500 Added 8.0%
47,253 $2.12 Million
Q2 2022

Aug 12, 2022

SELL
$53.22 - $123.09 $266,100 - $615,450
-5,000 Reduced 10.26%
43,753 $2.59 Million
Q1 2022

May 13, 2022

SELL
$101.89 - $150.09 $374,547 - $551,730
-3,676 Reduced 7.01%
48,753 $5.67 Million
Q4 2021

Feb 14, 2022

SELL
$118.18 - $153.21 $420,248 - $544,814
-3,556 Reduced 6.35%
52,429 $7.89 Million
Q3 2021

Nov 12, 2021

SELL
$93.51 - $129.4 $841,590 - $1.16 Million
-9,000 Reduced 13.85%
55,985 $6.68 Million
Q1 2021

May 14, 2021

BUY
$81.28 - $104.34 $4.1 Million - $5.27 Million
50,485 Added 348.17%
64,985 $5.74 Million
Q2 2020

Aug 13, 2020

BUY
$60.05 - $98.92 $300,250 - $494,600
5,000 Added 52.63%
14,500 $1.43 Million
Q1 2020

May 14, 2020

BUY
$47.37 - $90.04 $450,015 - $855,380
9,500 New
9,500 $611,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.31B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Formula Growth LTD Portfolio

Follow Formula Growth LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formula Growth LTD, based on Form 13F filings with the SEC.

News

Stay updated on Formula Growth LTD with notifications on news.